Human 4-1BB Ligand/TNFSF9 Antibody, R&D Systems™

4-1BB Ligand/TNFSF9

LYOPH

Western Blot, Flow Cytometry, CyTOF

Unconjugated

Mouse

Human

P41273.1

8744

E. coli-derived recombinant human 4-1BB Ligand/TNFSF9 Arg71-Glu254 Accession # P41273.1

Primary

Reconstitute at 0.5 mg/mL in sterile PBS.

Detects human 4-1BB Ligand/TNFSF9 Ligand in direct ELISAs and Western blots. In Western blots, no cross-reactivity with recombinant mouse (rm) 4-1BB Ligand, recobinant human (rh) APRIL, rhBAFF, rmEDA-A2, rhFas Ligand, rhGITR Ligand, rhLIGHT, rhLymphotoxin alpha 1/beta 2, rhLymphotoxin alpha 2/beta 1, rhOX40 Ligand, rhTNF-alpha , rhTRAIL, rhTRANCE, or rhTWEAK is observed.

282220

Western Blot 1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready

Monoclonal

Purified

RUO

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

4-1BB ligand, 41BB Ligand, 4-1BBL, 4-1BB-L, CD137L, homolog of mouse 4-1BB-L, receptor 4-1BB ligand, TNFSF9, tumor necrosis factor (ligand) superfamily, member 9, tumor necrosis factor ligand superfamily member 9

TNFSF9

IgG2b

Protein A or G purified from hybridoma culture supernatant

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.